Search
for
Sort by
Research 31–60 of 173
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Hirsutism and the Variable Response of the Pilosebaceous Unit to Androgen
- 46,XY DSD due to impaired androgen production
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Nonclassic Congenital Adrenal Hyperplasia
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Chronic Stress Suppresses the Expression of Cutaneous Hypothalamic–Pituitary–Adrenocortical Axis Elements and Melanogenesis
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Biosynthesis of Dihydrotestosterone by a Pathway that Does Not Require Testosterone as an Intermediate in the SZ95 Sebaceous Gland Cell Line
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
- Use of Insulin-Sensitizing Agents in Patients With Polycystic Ovary Syndrome
- Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)
- Polycystic ovarian syndrome
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- PCOS: update and diagnostic approach
- MANAGEMENT OF ENDOCRINE DISEASE Hyperandrogenic states in women: pitfalls in laboratory diagnosis
- Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters
- Targets to treat androgen excess in polycystic ovary syndrome